Latest Expert Opinions

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
November 26, 2018
This is a good company but he has trouble with the valuation. The return on capital has been improving the last few years which is a good sign. It looks very expensive. They have a lot of debt. He has some concern and would probably not buy.
First Data Corp (FDC-N)
November 26, 2018
This is a good company but he has trouble with the valuation. The return on capital has been improving the last few years which is a good sign. It looks very expensive. They have a lot of debt. He has some concern and would probably not buy.
Matt Kacur
President, FSA Financial Science and Art
Price
$0.000
Owned
No
WEAK BUY
WEAK BUY
November 26, 2018
This is a global player in energy. He expects the stock will go mainly sideways. You get a dividend. He would not expect a large appreciation in stock price but should be part of a balanced portfolio.
Suncor Energy Inc (SU-T)
November 26, 2018
This is a global player in energy. He expects the stock will go mainly sideways. You get a dividend. He would not expect a large appreciation in stock price but should be part of a balanced portfolio.
Matt Kacur
President, FSA Financial Science and Art
Price
$43.150
Owned
No
DON'T BUY
DON'T BUY
November 26, 2018
This is primarily a Canadian energy company and therefore getting low prices for oil. It is hard to support the valuation. Yield is almost 8.5%, so should be cautious. Their debt level is not too bad. They are in a very tough sector.
This is primarily a Canadian energy company and therefore getting low prices for oil. It is hard to support the valuation. Yield is almost 8.5%, so should be cautious. Their debt level is not too bad. They are in a very tough sector.
Matt Kacur
President, FSA Financial Science and Art
Price
$32.700
Owned
No
WAIT
WAIT
November 26, 2018
Has had a pullback over the last 3 years. Their return on capital has gone down. They have had tough competition and some products going off patent. He would wait to see improved results before he decided on a position.
Has had a pullback over the last 3 years. Their return on capital has gone down. They have had tough competition and some products going off patent. He would wait to see improved results before he decided on a position.
Matt Kacur
President, FSA Financial Science and Art
Price
$66.530
Owned
No
BUY
BUY
November 26, 2018
He likes this company. It has come down quite a bit over the last couple of years. There was some talk of the supply chain being over bloated. The merger with Aetna should be a net benefit. Good opportunity at this level.
CVS Health Corp (CVS-N)
November 26, 2018
He likes this company. It has come down quite a bit over the last couple of years. There was some talk of the supply chain being over bloated. The merger with Aetna should be a net benefit. Good opportunity at this level.
Matt Kacur
President, FSA Financial Science and Art
Price
$77.840
Owned
No
WAIT
WAIT
November 26, 2018
He can not endorse this company right now. It looks like a good company but does not see a lot of financial disclosure regarding their recent acquisition. It does seem to make strategic sense. He has to wait to see what happens.
BlackBerry (BB-T)
November 26, 2018
He can not endorse this company right now. It looks like a good company but does not see a lot of financial disclosure regarding their recent acquisition. It does seem to make strategic sense. He has to wait to see what happens.
Matt Kacur
President, FSA Financial Science and Art
Price
$11.790
Owned
No
BUY
BUY
November 26, 2018
He likes this company. They just re-entered his radar screen. It has the profile they are looking for. He is 100% behind this one.
He likes this company. They just re-entered his radar screen. It has the profile they are looking for. He is 100% behind this one.
Matt Kacur
President, FSA Financial Science and Art
Price
$43.650
Owned
No